Fact CheckerSign in

NCT07440563Enrolling by invitation

Auricular Vagus Nerve Stimulation Combined With Rehabilitation in Parkinson's Disease

Investigation of the Effects of Auricular Vagus Nerve Stimulation Combined With Neurological Physiotherapy and Rehabilitation on Balance, Gait, and Clinical Symptoms in People With Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 5 Mar 2026

Brief summary (registry, in English)

Parkinson's disease (PD) is a progressive, neurodegenerative movement disorder characterized by a combination of motor and non-motor symptoms. Auricular vagus nerve stimulation (aVNS), one of the physiotherapy methods used in PD, has been shown in studies to have a positive effect on symptoms such as motor symptoms, gait disturbance, freezing, and cognitive impairment, and is considered a safe and feasible method. The aim of this study is to investigate the effects of neurological physiotherapy and rehabilitation, in combination with aVNS application, on balance, gait, and clinical symptoms in individuals with PD.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
20 (estimated)
First submitted
16 Feb 2026
Start date
3 Mar 2026
Primary completion date
23 Mar 2027
Lead sponsor
Gazi University
NCT number
NCT07440563

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 3 Mar 2026 to the primary completion date, 23 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Presence of metallic implants in the head or neck region

Other illness

  • Presence of additional neurological (e.g., migraine), orthopedic (e.g., osteoarthritis), or cardiovascular conditions (e.g., myocardial infarction, uncontrolled hypertension, arrhythmias)
  • Presence of a cardiac pacemaker
  • History of deep brain stimulation surgery

Other

  • Score below 21 on the Montreal Cognitive Assessment (MoCA)
  • Presence of uncorrected visual or hearing impairments

Who the study is looking for

  • Diagnosis of Parkinson's disease confirmed by a neurologist according to the United Kingdom Brain Bank criteria
  • Age 40 years or older
  • Hoehn and Yahr stage between 1 and 3 according to the Modified Hoehn and Yahr Staging Scale
  • Stable pharmacological treatment regimen
  • Ability to turn 180 degrees and walk 30 meters independently without assistance

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gazi University
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.